PLEKNA

Table of contents:

The "PLEKNA" trademark, serial number 79049443 , was filed on 12th of December 2007 with a mark drawing code of 4000 and its transaction date is 79049443. Since 29th of May 2014, the document can be found in the M60 law office in the publication and issue section. The employee responsible is POVARCHUK, REBECCA JOY and the date it was published for opposition on 05/06/2008. The status of this trademark was checked last on 05/13/2014.

The "PLEKNA" trademark, serial number 86142915 , was filed on 13th of December 2013 with a mark drawing code of 4000 and its transaction date is 86142915. The attorney assigned is Martin J. Beran, attorney docket number T/3974-566. Since 30th of May 2014, the document can be found in the M30 law office in the publication and issue section. The status of the trademark was checked last on 05/30/2014.

The corresponded responsible for this trademark is MARTIN J. BERAN, located at OSTROLENK FABER LLP, 1180 AVENUE OF THE AMERICAS FL 7, NEW YORK, NY 10036-8443.

The state or country where the trademark was organized is by Boehringer Ingelheim International Gmbh. The legal entity type behing it is a Corporation, located at 55218, Ingelheim, zip .Other trademarks by this applicant: HCVERSO, FASILITO, DYNAGITO.

GOODS AND/OR SERVICES
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
U.S. Class052 - Detergents and Soaps
Class Status6 - Active
Status Date12/27/2013
Primary Code005
Goods codes
GS0051Pharmaceutical preparations and substances for the treatment of diseases and disorders of the alimentary tract and metabolism, blood and blood forming organs, the cardiovascular system, the musculoskeletal system, the central nervous system, the peripheral nervous system, the genitourinary system, the respiratory system and dermatological orders; hormones for medical purposes; anti-infective preparations; anti-viral preparations; cystostatic preparations for the use in the treatment of cancer
PROSECUTION HISTORY
DateDescriptionTypeCode
05/30/2014 AMENDMENT FROM APPLICANT ENTERED I - Incoming Correspondence ACEC - AMENDMENT FROM APPLICANT ENTERED
05/30/2014 CORRESPONDENCE RECEIVED IN LAW OFFICE I - Incoming Correspondence CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE
05/30/2014 PAPER RECEIVED I - Incoming Correspondence MAIL - PAPER RECEIVED
05/19/2014 NOTIFICATION OF LETTER OF SUSPENSION E-MAILED O - Outgoing Correspondence GNS3
05/19/2014 LETTER OF SUSPENSION E-MAILED S GNSL - LETTER OF SUSPENSION E-MAILED
05/19/2014 SUSPENSION LETTER WRITTEN R - Renewal CNSL - SUSPENSION LETTER WRITTEN
05/15/2014 AMENDMENT FROM APPLICANT ENTERED I - Incoming Correspondence ACEC - AMENDMENT FROM APPLICANT ENTERED
05/15/2014 CORRESPONDENCE RECEIVED IN LAW OFFICE I - Incoming Correspondence CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE
05/15/2014 ASSIGNED TO LIE A - Allowance for Publication ALIE - ASSIGNED TO LIE
05/05/2014 PAPER RECEIVED I - Incoming Correspondence MAIL - PAPER RECEIVED
01/07/2014 NOTIFICATION OF NON-FINAL ACTION E-MAILED O - Outgoing Correspondence GNRN
01/07/2014 NON-FINAL ACTION E-MAILED F - First Action GNRT - NON-FINAL ACTION E-MAILED
01/07/2014 NON-FINAL ACTION WRITTEN R - Renewal CNRT - NON-FINAL ACTION WRITTEN
01/07/2014 ASSIGNED TO EXAMINER D - Assigned to Examiner DOCK - ASSIGNED TO EXAMINER
12/27/2013 NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM I - Incoming Correspondence NWOS
12/17/2013 NEW APPLICATION ENTERED IN TRAM I - Incoming Correspondence NWAP - NEW APPLICATION ENTERED IN TRAM


Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.

Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.